Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Rxo (RXO) FCF Margin (2021 - 2025)

Historic FCF Margin for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to 0.61%.

  • Rxo's FCF Margin rose 5300.0% to 0.61% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.14%, marking a year-over-year increase of 11100.0%. This contributed to the annual value of 0.14% for FY2025, which is 11100.0% up from last year.
  • As of Q4 2025, Rxo's FCF Margin stood at 0.61%, which was up 5300.0% from 0.63% recorded in Q3 2025.
  • Rxo's 5-year FCF Margin high stood at 6.94% for Q1 2022, and its period low was 1.73% during Q3 2024.
  • In the last 5 years, Rxo's FCF Margin had a median value of 0.63% in 2025 and averaged 1.17%.
  • Its FCF Margin has fluctuated over the past 5 years, first skyrocketed by 31400bps in 2022, then tumbled by -51300bps in 2023.
  • Rxo's FCF Margin (Quarter) stood at 2.03% in 2021, then soared by 155bps to 5.18% in 2022, then tumbled by -98bps to 0.1% in 2023, then crashed by -1215bps to 1.14% in 2024, then soared by 46bps to 0.61% in 2025.
  • Its last three reported values are 0.61% in Q4 2025, 0.63% for Q3 2025, and 0.63% during Q2 2025.